The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized, double-blind, phase III trial of a personalized peptide vaccination for human leukocyte antigen-A24-positive glioblastoma multiforme patients refractory to temozolomide-based therapy.
 
Mizuhiko Terasaki
No Relationships to Disclose
 
Yoshitaka Narita
Honoraria - Abbvie; Chugai Pharma; Daiichi Sankyo; Eisai; MSD; Otsuka
Consulting or Advisory Role - Abbvie
Research Funding - Abbvie; Chugai Pharma; Daiichi Sankyo; Eisai; EPS Associates Co., Ltd.; GlaxoSmithKline; Meiji Seika Kaisha; MSD; Ono Pharmaceutical; Otsuka; SBI Pharmaceuticals; Stella pharma; Toshiba
 
Yoshiki Arakawa
Research Funding - Chugai Pharma; Eisai; Meiji Seika Kaisha; Merck
 
Kazuhiko Sugiyama
Honoraria - Chugai Pharma; Eisai; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma; Eisai; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
 
Tomokazu Aoki
No Relationships to Disclose
 
Masayuki Kanamori
Research Funding - Eisai
 
Motoo Nagane
Honoraria - Abbvie; Bayer Schering Pharma; BIOMEDIS International; Chugai Pharma; Daiichi Sankyo; Eisai; MSD; Nobelpharma; Novartis; Novocure; Ono Pharmaceutical; Otsuka
Consulting or Advisory Role - Abbvie; Chugai Pharma; Novartis; Novocure; Ono Pharmaceutical; Otsuka
Research Funding - Abbvie (Inst); Bayer Schering Pharma; Chugai Pharma (Inst); CSL Behring; Eisai (Inst); GlaxoSmithKline K.K.; HOYA Techonosurgical; HOYA Techonosurgical; Johnson & Johnson; Kyowa Hakko Kirin (Inst); Medico's Hirata; Mitsubishi Tanabe Pharma; MSD (Inst); Ono Pharmaceutical (Inst); Otsuka; Pfizer; Saney Seiko; Sanofi; Takeda; Tsumura & Co.
 
Toshihiro Kumabe
Honoraria - Chugai Pharma; Daiichi Sankyo; Eisai; GlaxoSmithKline; MSD; Otsuka; Santen; Takeda; Teijin Pharma; Tsumura & Co.
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Chugai Pharma; Coridien; Daiichi Sankyo; Eisai; Kyocera; MSD; Nihon Medi-Physics; Otsuka; Pfizer; Takeda; Teijin Pharma
Travel, Accommodations, Expenses - Chugai Pharma; Daiichi Sankyo; Eisai; GlaxoSmithKline; MSD; Otsuka; Santen; Takeda; Teijin Pharma; Tsumura & Co.
 
Yuichi Hirose
Honoraria - Chugai Pharma; Daiichi Sankyo; Eisai; MSD; Otsuka
Research Funding - Chugai Pharma; Daiichi Sankyo; Eisai; MSD; Otsuka; Pfizer; Takeda
 
Tomotsugu Ichikawa
No Relationships to Disclose
 
Takamitsu Fujimaki
No Relationships to Disclose
 
Hiroyuki Kobayashi
No Relationships to Disclose
 
Hisaharu Goto
No Relationships to Disclose
 
Hideo Takeshima
No Relationships to Disclose
 
Tetsuya Ueba
No Relationships to Disclose
 
Hiroshi Abe
No Relationships to Disclose
 
Takashi Tamiya
No Relationships to Disclose
 
Yukihiko Sonoda
Speakers' Bureau - Chugai Pharma; Daiichi Sankyo; Eisai; MSD
Research Funding - Astellas Pharma; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; Eisai; Fujifilm; HOYA Techonosurgical; MSD; Otsuka; Takeda; Tsumura & Co.
 
Tatsuyuki Kakuma
No Relationships to Disclose
 
Ryo Nishikawa
Honoraria - Chugai Pharma; Eisai; MSD; Nobelpharma
Consulting or Advisory Role - Novocure; Ono Pharmaceutical
Research Funding - Chugai Pharma (Inst); Eisai (Inst); MSD (Inst)